Related Experiment Videos
Investigation of lipids. What do the results really mean?
1Royal Prince Alfred Hospital, New South Wales.
Insights
Understanding your lipid profile is key for cardiovascular disease (CVD) risk assessment. Measuring high-density lipoprotein cholesterol (HDL-C) and calculating low-density lipoprotein cholesterol (LDL-C) provides a clearer picture than total cholesterol alone.
Area of Science:
- Cardiology
- Clinical Biochemistry
- Public Health
Background:
- National Heart Foundation guidelines recommend plasma lipid measurement for adult cardiovascular disease (CVD) risk assessment.
- Focusing solely on total cholesterol is less informative than assessing individual lipoproteins like low-density lipoprotein (LDL) and high-density lipoprotein (HDL).
Purpose of the Study:
- To review laboratory lipid measurement considerations.
- To discuss the interpretation of lipid profiles for clinical decision-making.
Main Methods:
- Analysis of current recommendations for lipid testing.
- Review of established guidelines for interpreting lipid profiles.
Main Results:
- Optimal assessment includes total cholesterol, triglycerides, and HDL-C, enabling LDL-C calculation.
- LDL-C levels, considered alongside overall CVD risk factors, guide treatment decisions.
Conclusions:
- Accurate CVD risk assessment relies on comprehensive lipid profiling, not just total cholesterol.
- Tailored treatment strategies are informed by calculated LDL-C and patient-specific risk factors.
- Additional laboratory tests can supplement diagnosis and clinical management.
Background:
The National Heart foundation recommends that all adult Australians should have their plasma lipids measured to help assess their risk of cardiovascular disease (CVD). Patients usually concentrate on their total cholesterol result, but this is less informative than the levels of individual lipoproteins, particularly low density lipoprotein (LDL) and high density lipoprotein (HDL).
Objective:
To discuss the considerations behind laboratory lipid measurements and their interpretation.
Discussion:
Adult patients are best assessed with total cholesterol, triglyceride and HDL-C allowing calculation of LDL-C. Treatment decisions should be based on LDL-C levels in the context of the overall risk factor status of the patient for CVD. Additional laboratory tests are available, some of which may assist with diagnosis or clinical decision making.